Source author record

Lan Liu

Lan Liu appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

7works
5topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

7 published item(s)

preprint2022arXiv

Semiparametric Efficient Dimension Reduction in multivariate regression with an Inner Envelope

Recently, Su and Cook proposed a dimension reduction technique called the inner envelope which can be substantially more efficient than the original envelope or existing dimension reduction techniques for multivariate regression. However, their technique relied on a linear model with normally distributed error, which may be violated in practice. In this work, we propose a semiparametric variant of the inner envelope that does not rely on the linear model nor the normality assumption. We show that our proposal leads to globally and locally efficient estimators of the inner envelope spaces. We also present a computationally tractable algorithm to estimate the inner envelope. Our simulations and real data analysis show that our method is both robust and efficient compared to existing dimension reduction methods in a diverse array of settings.

preprint2021arXiv

Envelopes for multivariate linear regression with linearly constrained coefficients

A constrained multivariate linear model is a multivariate linear model with the columns of its coefficient matrix constrained to lie in a known subspace. This class of models includes those typically used to study growth curves and longitudinal data. Envelope methods have been proposed to improve estimation efficiency in the class of unconstrained multivariate linear models, but have not yet been developed for constrained models that we develop in this article. We first compare the standard envelope estimator based on an unconstrained multivariate model with the standard estimator arising from a constrained multivariate model in terms of bias and efficiency. Then, to further improve efficiency, we propose a novel envelope estimator based on a constrained multivariate model. Novel envelope-based testing methods are also proposed. We provide support for our proposals by simulations and by studying the classical dental data and data from the China Health and Nutrition Survey and a study of probiotic capacity to reduced Salmonella infection.

preprint2020arXiv

Regression-based Negative Control of Homophily in Dyadic Peer Effect Analysis

A prominent threat to causal inference about peer effects over social networks is the presence of homophily bias, that is, social influence between friends and families is entangled with common characteristics or underlying similarities that form close connections. Analysis of social network data has suggested that certain health conditions such as obesity and psychological states including happiness and loneliness can spread over a network. However, such analyses of peer effects or contagion effects have come under criticism because homophily bias may compromise the causal statement. We develop a regression-based approach which leverages a negative control exposure for identification and estimation of contagion effects on additive or multiplicative scales, in the presence of homophily bias. We apply our methods to evaluate the peer effect of obesity in Framingham Offspring Study.

preprint2020arXiv

Resonant contributions to three-body $B_{(s)} \to [ D^{(*)}, \bar{D}^{(*)} ] K^+K^-$ decays in the perturbative QCD approach

In this work, we study the $S$, $P$ and $D$ wave resonance contributions to three-body decays $B_{(s)} \to [ D^{(*)}, \bar{D}^{(*)} ] K^+K^-$ by employing the perturbative QCD (PQCD) approach, where the kaon-kaon invariant mass spectra are dominated by the $f_0(980),f_0(1370),$ $ϕ(1020),ϕ(1680),f_2(1270),f^{\prime}_2(1525),f_2(1750)$ and $f_2(1950)$ resonances. The $KK$ $S$-wave component $f_0(980)$ is modeled with the Flatté formalism, while other resonances are described by the relativistic Breit-Wigner (BW) line shape. The corresponding decay channels are studied by constructing the kaon-kaon distribution amplitude $Φ_{KK}$, which captures important final state interactions between the kaon pair in the resonant region. We found that the PQCD predictions for the branching ratios for most considered decays agree with currently available data within errors. The associated polarization fractions of those vector-vector and vector-tensor decay modes are also predicted, which are expected to be tested in the near future experiments. The invariant mass spectra for the corresponding resonances in the $B_{(s)} \to [D^{(*)}, \bar{D}^{(*)} ] K^+K^-$ decays are well established, which can be confronted with the precise data from the LHCb and Belle II experiments.

preprint2016arXiv

Assessing the Treatment Effect Heterogeneity with a Latent Variable

The average treatment effect (ATE) is popularly used to assess the treatment effect. However, the ATE implicitly assumes a homogenous treatment effect even amongst individuals with different characteristics. In this paper, we mainly focus on assessing the treatment effect heterogeneity, which has important implications in designing the optimal individual treatment regimens and in policy making. The treatment benefit rate (TBR) and treatment harm rate (THR) have been defined to characterize the magnitude of heterogeneity for binary outcomes. When the outcomes are continuous, we extend the definitions of the TBR and THR to compare the difference between potential outcomes with a pre-specified level c. Unlike the ATE, these rates involve the joint distribution of the potential outcomes and can not be identified without further assumptions even in randomized clinical trials. In this article, we assume the potential outcomes are independent conditional on the observed covariates and an unmeasured latent variable. Under this assumption, we prove the identification of the TBR and THR in non-separable (generalized) linear models for both continuous and binary outcomes. We then propose estimators and derive their asymptotic distributions. In the simulation studies, we implement our proposed methods to assess the performance of our estimators and carry out a sensitive analysis for different underlying distribution for the latent variable. Finally, we illustrate the proposed methods in two randomized controlled trials.

preprint2016arXiv

Identification and Inference for Marginal Average Treatment Effect on the Treated With an Instrumental Variable

In observational studies, treatments are typically not randomized and therefore estimated treatment effects may be subject to confounding bias. The instrumental variable (IV) design plays the role of a quasi-experimental handle since the IV is associated with the treatment and only affects the outcome through the treatment. In this paper, we present a novel framework for identification and inference using an IV for the marginal average treatment effect amongst the treated (ETT) in the presence of unmeasured confounding. For inference, we propose three different semiparametric approaches: (i) inverse probability weighting (IPW), (ii) outcome regression (OR), and (iii) doubly robust (DR) estimation, which is consistent if either (i) or (ii) is consistent, but not necessarily both. A closed-form locally semiparametric efficient estimator is obtained in the simple case of binary IV and outcome and the efficiency bound is derived for the more general case.

preprint2016arXiv

Novel Criteria to Exclude the Surrogate Paradox and Their Optimalities

When the primary outcome is hard to collect, surrogate endpoint is typically used as a substitute. However, even when the treatment has a positive average causal effect (ACE) on the surrogate endpoint, which also has a positive ACE on the primary outcome, it is still possible that the treatment has a negative ACE on the primary outcome. Such a phenomenon is called the surrogate paradox and greatly challenges the use of surrogate. In this paper, we provide novel criteria to exclude the surrogate paradox. Unlike other conditions previously proposed, our conditions are testable since they only involve observed data. Furthermore, our criteria are optimal in the sense that they are sufficient and "almost necessary" to exclude the paradox: if the conditions are satisfied, the surrogate paradox is guaranteed to be absent while if the conditions fail, there exists a data generating process with surrogate paradox that can generate the same observed data. That is, our criteria capture all the information in the observed data to exclude the surrogate paradox rather than relying on unverifiable distributional assumptions.